52-1983273 · Washington, DC
TO DRIVE COLLABORATION AMONG PARTNERS FROM EVERY HEALTHCARE SECTOR TO POWER ADVANCES IN SCIENCE, POLICY AND REGULATION THAT SPEED LIFE-SAVING TREATMENTS TO PATIENTS.
Total revenue
$7.2M
FY2023
Total expenses
$5.2M
FY2023
Net assets
$15.8M
FY2023
Operating margin
27%
NPLens analysis
FY18–FY2023 · from annual filings
Financial health
B
Derived analysis — not an official IRS designation.
Computed from FY2023 · derived analysis
FY2023 · program vs. administration vs. fundraising (Form 990, Part IX)
FY2023 · where revenue comes from (as reported)
Highest-paid officers, directors & key employees · FY2023.
Jeff Allen PhD
President & CEO
$738,623
Ryan Hohman JD
VP-Public Affairs
$306,767
Mark Stewart PhD
VP-Science Policy
$274,388
Heather Chaney
VP-Operations
$227,979
Hillary Andrews
Dir.-Reg & Res Par
$177,971
Each figure on this page traces to one of these source returns.
Health scores, efficiency ratios, peer percentiles, and outlier flags are derived analysis by NPLens — not official IRS designations. Figures are as reported on the organization's Form 990 filings. How these are computed →